GPCR
Price:
$36.95
Market Cap:
$2.11B
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073, a biased agonist, targeting apelin receptor, a GPCR that has been implicated in idiopathic pulmonary fibrosis (IPF) and pu...[Read more]
Industry
Biotechnology
IPO Date
2023-02-03
Stock Exchange
NASDAQ
Ticker
GPCR
According to Structure Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.74B. This represents a change of -1.67% compared to the average of 1.77B of the last 4 quarters.
The mean historical Enterprise Value of Structure Therapeutics Inc. over the last ten years is 1.03B. The current 1.74B Enterprise Value has changed 16.69% with respect to the historical average. Over the past ten years (40 quarters), GPCR's Enterprise Value was at its highest in in the September 2023 quarter at 1.89B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.
Average
1.03B
Median
951.23M
Minimum
860.71M
Maximum
1.37B
Discovering the peaks and valleys of Structure Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 59.51%
Maximum Annual Enterprise Value = 1.37B
Minimum Annual Increase = -9.51%
Minimum Annual Enterprise Value = 860.71M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.37B | 59.51% |
2022 | 860.71M | -9.51% |
2021 | 951.19M | -0.01% |
The current Enterprise Value of Structure Therapeutics Inc. (GPCR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.06B
5-year avg
1.03B
10-year avg
1.03B
Structure Therapeutics Inc.’s Enterprise Value is greater than Day One Biopharmaceuticals, Inc. (1.01B), greater than X4 Pharmaceuticals, Inc. (40.79M), greater than Inozyme Pharma, Inc. (343.89M), greater than Acumen Pharmaceuticals, Inc. (93.64M), greater than Mereo BioPharma Group plc (582.99M), greater than Terns Pharmaceuticals, Inc. (458.36M), greater than Amylyx Pharmaceuticals, Inc. (89.50M), greater than Eledon Pharmaceuticals, Inc. (75.34M), greater than HOOKIPA Pharma Inc. (87.25M), greater than Biomea Fusion, Inc. (153.42M), greater than Disc Medicine, Inc. (997.59M), less than DICE Therapeutics, Inc. (2.21B), less than Morphic Holding, Inc. (2.81B),
Company | Enterprise Value | Market cap |
---|---|---|
1.01B | $1.25B | |
40.79M | $109.78M | |
343.89M | $312.42M | |
93.64M | $133.38M | |
582.99M | $664.26M | |
458.36M | $549.60M | |
89.50M | $161.36M | |
75.34M | $100.73M | |
87.25M | $159.50M | |
153.42M | $256.37M | |
997.59M | $1.50B | |
2.21B | $2.27B | |
2.81B | $2.86B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Structure Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Structure Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Structure Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Structure Therapeutics Inc. (GPCR)?
What is the 3-year average Enterprise Value for Structure Therapeutics Inc. (GPCR)?
What is the 5-year average Enterprise Value for Structure Therapeutics Inc. (GPCR)?
How does the current Enterprise Value for Structure Therapeutics Inc. (GPCR) compare to its historical average?